Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rivaroxaban vs Warfarin in Lower-limb DVT
NCT02704598Unknown
- Sponsor
- Hospital do Servidor Público Estadual
- Start
- Mar 2016
- Primary completion
- Dec 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial of rivaroxaban in deep vein thrombosis (DVT) (2 arms), sponsored by Hospital do Servidor Público Estadual. Primary endpoints: Recanalization Rate at 12 months and Incidence of Postthrombotic Syndrome at 12 months. Status: unknown.
02
Drugs
rivaroxaban
03
Conditions
deep vein thrombosis (DVT)
Beyond the preview
Go deeper on NCT02704598.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02704598.